Lori Montgomery oversees coverage of business, the economy and technology. Before becoming an editor, she was a reporter covering U.S. economic policy, with a focus on efforts to tame the national ...

Dr. Lori Montgomery is recruiting people for a clinical trial using a safe, well tolerated drug for gout, probenecid, to help with the disabling symptoms of opioid withdrawal.

Montgomery, a 25-year Post veteran, will focus on extending the Post’s reporting and analysis about the politicians, policy and powers in Washington, DC and across the country. Montogomery has ...